Roberta Santos Azevedo^1*, Mariia Mikhaleva, MD^2*, Kiyomi Mashima, MD, PhD², Stephen Martindale, BS^2*, Stacey M. Fernandes, BS^2*, Svitlana Tyekucheva, PhD^2,3*, Inhye E. Ahn, MD^2,4, Matthew S. Davids, MD, MMSc^2,4 and Jennifer R. Brown, MD, PhD^2,4

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston
⁴Department of Medicine, Harvard Medical School, Boston, MA

Anne Sophie Michallet, MD, PhD^1,2*, Remi Letestu^3*, Magali Legarff^4*, Stéphane Morisset^5*, Therese Aurran-Schleinitz, MD^6*, Kamel Laribi^7*, Vincent Levy, MD, PhD^8*, Laurence Simon^9*, Damien Roos Weil, MD^10*, Marie Sarah Dilhuydy, MD^11*, Cecile Tomowiak, MD^12*, Caroline Dartigeas, MD^13*, Romain Guieze, MD, PhD^14*, Olivier Tournilhac^15*, Emmanuelle Ferrant^16*, Sophie De Guibert^17*, Pierre Feugier, MD, PhD^18*, Fatiha Merabet, MD^19*, Stéphane Lepretre^20*, Philippe Carassou^21*, Julie Gay^22*, Benedicte Hivert^23*, Luc-Matthieu Fornecker, MD, PhD^24*, Jehan Dupuis, MD^25*, Lysiane Molina, MD^26*, Bruno Villemagne, MD^27*, Guillaume Cartron, MD, PhD^28*, Bernard Drenou, MD^29*, Omar Benbrahim, MD^30*, Xavier Cahu^31*, Florence Nguyen Khac^32*, Valerie Rouillé^33*, Loic Ysebaert, MD, PhD^34* and Anne Quinquenel^35*

¹Hematology department, Robert Debré University Hospital, Reims, France
²UFR Médecine, Université Reims Champagne-Ardenne, Reims, France
³avicennes hospital, Avicennes, France
⁴APHP La pitié salpetriere, Paris, France
⁵Centre Léon Bérard, Fi-LMC, Lyon, France
⁶IPC, marseille, France
⁷CH Le Mans, Le mans, France
⁸Centre de Recherche Clinique, Hôpital Avicenne, AP-HP et Université Sorbonne, Paris, France
⁹hospital Corbeil essonnes, Corbeil-Essonnes, FRA
¹⁰Clinical Hematology, APHP, La Pitié Salpétriere, Sorbonne Universite, Paris, FRA
¹¹CHU Bordeaux, PESSAC, FRA
¹²Hematology department & CIC 1402, Poitiers University Hospital, Poitiers, France
¹³CHU Bretonneau, Tours, FRA
¹⁴CHU Estaing, Clermont Ferrand, FRA
¹⁵CHU Estaing, Clermont-Ferrand University Hospital, CLERMONT FERRAND, AURA, France
¹⁶Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
¹⁷Centre Hospitalier Pontchaillou, Rennes, FRA
¹⁸CHU Brabois - Service d'Hématologie - Université Henri Poincaré, Nancy, France
¹⁹andre mignot hospital, LE CHESNAY, FRA
²⁰centre henri becquerel, Rouen, FRA
²¹Centre Hospitalier Regional Metz-Thionville, Hopital Mercy, Metz, France
²²CH Côte basque, Bayonne, FRA
²³GHICL, Lille, FRA
²⁴Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
²⁵APHP, Creteil, Creteil, FRA
²⁶CHU grenoble, grenoble, France
²⁷CH la roche sur yon, La Roche Sur Yon, FRA
²⁸Centre Hospitalier Universitaire de Montpellier, Montpellier, France
²⁹Laboratoire d'Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France
³⁰HOPITAL LA SOURCE, La Source, FRA
³¹hospital cesson sevigne, cesson sevigne, France
³²Hôpital Pitié-Salpêtrière, Service d'Hématologie, Paris, France
³³CHU montpellier, montpellier, France
³⁴Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
³⁵CHU reims, reims, France

Talha Munir, MBBS, PhD^1,2,3,4, Abraham Mullasseril Varghese, MBBS, MRCP , PhD⁴, Adrian Bloor, Phd FRCP FRCPath^5*, David Allsup, MD^6*, Kate Cwynarski, MBBS, PhD, FRCP, FRCPath^7,8*, Andrew Pettitt^9*, Shankara Paneesha^10*, Christopher P Fox, PhD¹¹, Toby A. Eyre^12*, Francesco Forconi^13*, Nagah Elmusharaf^14*, Ben Kennedy^15*, Prof. John G. Gribben, MD, DSc¹⁶, Nicholas Pemberton^17*, Oonagh Sheehy^18*, Gavin Preston, PhD, MBBS, FRCP, FRCPath^19*, Anna Schuh, MD²⁰, Anna Hockaday^21*, David A. Cairns, PhD^22*, Sharon Jackson^21*, Natasha Greatorex^21*, Sean Girvan^21*, Sue Bell^21*, David Stones^21*, Nichola McWhirter^23*, Surita Dalal, PhD^24*, Andrew Rawstron, PhD^25*, Piers Patten, FRCP, FRCPath, PhD²⁶ and Peter Hillmen^27*

¹Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
²Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
³Haematology, Haematological Malignancy Diagnostic Service (HMDS), St. James’s Institute of Oncology, Leeds, United Kingdom
⁴Department of Haematology, St James's University Hospital, Leeds, United Kingdom
⁵The Christie NHS Foundation Trust, Manchester, United Kingdom
⁶Castle Hill Hospital, Cottingham, GBR
⁷Consultant Haematologist UCLH Honorary Associate Professor UCL Chair NCRI T cell Lymphoma SubGroup, University College London Hospital, London, United Kingdom
⁸Department Of Hematology, Royal Free Hospital, London, United Kingdom
⁹Royal Liverpool University Hospital, Liverpool, GBR
¹⁰Birmingham Centre for Cellular Therapy and Transplant (BCCTT), Birmingham, United Kingdom
¹¹Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom
¹²Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Old Road, United Kingdom
¹³School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
¹⁴University Hospital of Wales, Cardiff, GBR
¹⁵Leicester Royal Infirmary, Leicester, GBR
¹⁶Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary, University of London, London, United Kingdom
¹⁷Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom
¹⁸Belfast Health and Social Care Trust, Belfast, United Kingdom
¹⁹Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
²⁰Department of Oncology, University of Oxford, Oxford, United Kingdom
²¹Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
²²Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
²³HMDS, St James's Hospital, Leeds, United Kingdom
²⁴Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom
²⁵Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
²⁶King’s College Hospital, London, GBR
²⁷The Leeds Teaching Hospitals, St. James Institute of Oncology, Waltham, MA

Christian Brieghel, MD, PhD^1*, Julie Dubois, MD, PhD^2*, Ida Kappel Buhl, MD, PhD^3*, Kazem Nasserinejad, PhD^4,5*, Dennis De Rooij^6*, Karl Nyrén, PhD^7*, Hoa T Tran, MD, PhD^8*, Sabina Kersting, MD, PhD^9*, Mattias Mattsson, MD^10*, Juha Ranti, MD^11*, Rogier Mous, MD PhD^12*, Gerrit Jan Veldhuis, MD^13*, Caspar da Cunha-Bang, MD, PhD^1*, Mark-David Levin¹⁴, Valtteri Wirta, PhD^7*, Richard Rosenquist, MD, PhD¹⁵, Arnon P. Kater, MD, PhD¹⁶ and Carsten Utoft Niemann, MD, PhD^1*

¹Department of Hematology, Rigshospitalet, Copenhagen, Denmark
²Department of Hematology, University of Amsterdam, Amsterdam, Netherlands
³Center for Genomic Medicine, Rigshospitalet, Glostrup, Denmark
⁴Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
⁵HOVON foundation, Rotterdam, Netherlands
⁶Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, NLD
⁷Science for Life Laboratory; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
⁸Akershus University Hospital, LøRenskog, NOR
⁹Department of Hematology, Haga Ziekenhuis, Den Haag, Netherlands
¹⁰Department of Hematology, Uppsala University Hospital, Uppsala, Sweden
¹¹Department of Hematology, Turku University Central Hospital, Turku, Finland
¹²Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
¹³Department of Hematology, Antonius Ziekenhuis, Sneek, Netherlands
¹⁴Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
¹⁵Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
¹⁶Amsterdam University Medical Center, Amsterdam, on behalf of HOVON, Netherlands

Sungchul Daniel Choi, MD¹, Yue Ren, MS^1*, Svitlana Tyekucheva, PhD^1*, Stacey M. Fernandes, BS^2*, Mariia Mikhaleva, MD^1*, Kiyomi Mashima, MD, PhD¹, Rayan Fardoun, MS^1*, Samantha J. Shupe, BS^1*, Stephen Martindale, BS^1*, Matthew S. Davids, MD, MMSc³, Jennifer R. Brown, MD, PhD¹ and Inhye E. Ahn, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA

Benjamin F. Frost^1,2,3*, Noelle Frey, MD, MS^1,4, Elizabeth O. Hexner, MD, MSTR^1,5, Stephen J. Schuster, MD^1,5,6, Sunita D. Nasta, MD^1,5,6, Alison W Loren, MD^1,7, Jakub Svoboda, MD^1,5,6, Daniel J. Landsburg, MD^1,5,6, Bruce Levine, PhD^1,3, Joseph A. Fraietta, PhD^1,8*, J. Joseph Melenhorst, PhD^1,3,9, Elizabeth Veloso, BSN^3*, Wei-Ting Hwang^1*, Carl H. June, MD^1,3,5, David L. Porter, MD^1,3,5,6 and Saar Gill, MD, PhD^1,4,8

¹Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Department of Medicine, Brigham and Women's Hospital, Boston, MA
³Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁴University of Pennsylvania, Philadelphia, PA
⁵Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
⁶Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁷Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA
⁸Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁹Center for Immunotherapy and Precision Immuno-Oncology, Cell Therapy & Immuno-Engineering Program, Lerner Research Institute, Cleveland Clinic, Cleveland, OH